Assessment of Unilateral Lymphoedema of the Leg

NCT00757406 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2009-04-16

No results posted yet for this study

Summary

To demonstrate that ImpediMed L-Dex U400 can be used to assess unilateral Lymphoedema of the leg using the same principles for arms.

Conditions

  • Lymphedema

Sponsors & Collaborators

  • ImpediMed Limited

    lead INDUSTRY

Principal Investigators

  • Robyn C Box, PhD · Qld Lymphoedema and Breast Oncology Physiotherapy

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2008-12-31
Completion
2009-01-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00757406 on ClinicalTrials.gov